Biofrontera Equity Warrants 27th Oct 2026 BFRIW:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/30/22 EDT
0.60UNCH (UNCH)
Volume
1
52 week range
0.28 - 9.18
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.60
  • 52 Week High9.18
  • 52 Week High Date12/21/21
  • 52 Week Low0.28
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.60
  • 52 Week High9.18
  • 52 Week High Date12/21/21
  • 52 Week Low0.28
  • 52 Week Low Date09/23/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biofrontera Equity Warrants 27th Oct 2026

 

Profile

MORE
Biofrontera Inc. is a biopharmaceutical company. The Company is specialized in the commercialization of pharmaceutical products for the treatment of dermatological conditions for the diseases caused primarily by exposure to sunlight that result in sun damage to the skin. Its products focus on the treatment of actinic keratoses, which are skin lesions that lead to skin cancer. It also markets a topical antibiotic for treatment of impetigo, a bacterial skin infection. The...
Hermann Lubbert Ph.D.
Executive Chairman of the Board
Erica Monaco CPA
Chief Executive Officer
Address
120 Presidential Way,, Suite 330
Woburn, MA
01801
United States